Brainomix 360 unlocks expert-level insights from universally available non-contrast CT scans, helping stroke networks expand access to life-changing treatments.
The FDA-cleared core volume is a novel and patented feature that enables physicians to assess ischemic core volume from widely available non-contrast CT (NCCT) images through the Brainomix 360 Stroke solution.
The core volume feature has been studied and validated by leading US stroke centers, with results demonstrating equivalency to CT Perfusion and MRI-derived core volume assessments. This addresses a longstanding unmet need in stroke triage, enabling physicians across stroke networks to access expert-level insights to improve decision making for treatment and transfer of patients using routinely available brain scans.